406 related articles for article (PubMed ID: 33110390)
1. Pleiotropic use of Statins as non-lipid-lowering drugs.
Zhang Q; Dong J; Yu Z
Int J Biol Sci; 2020; 16(14):2704-2711. PubMed ID: 33110390
[TBL] [Abstract][Full Text] [Related]
2. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
[TBL] [Abstract][Full Text] [Related]
3. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
Krysiak R; Okopień B; Herman Z
Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects of statins - mechanisms and consequences.
Bełtowski J; Wójcicka G; Jamroz-Wiśniewska A
Curr Drug Saf; 2009 Sep; 4(3):209-28. PubMed ID: 19534648
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis.
Arnaud C; Veillard NR; Mach F
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):127-34. PubMed ID: 15853754
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
7. Statins as Anticancer Agents in the Era of Precision Medicine.
Longo J; van Leeuwen JE; Elbaz M; Branchard E; Penn LZ
Clin Cancer Res; 2020 Nov; 26(22):5791-5800. PubMed ID: 32887721
[TBL] [Abstract][Full Text] [Related]
8. Statins: a repurposed drug to fight cancer.
Jiang W; Hu JW; He XR; Jin WL; He XY
J Exp Clin Cancer Res; 2021 Jul; 40(1):241. PubMed ID: 34303383
[TBL] [Abstract][Full Text] [Related]
9. Statin therapy-evidence beyond lipid lowering contributing to plaque stability.
de Lorenzo F; Feher M; Martin J; Collot-Teixeira S; Dotsenko O; McGregor JL
Curr Med Chem; 2006; 13(28):3385-93. PubMed ID: 17168712
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of statins on the vascular tissue.
Ikeda U; Shimada K
Curr Drug Targets Cardiovasc Haematol Disord; 2001 Jun; 1(1):51-8. PubMed ID: 12769664
[TBL] [Abstract][Full Text] [Related]
11. The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase.
Maciejak A; Leszczynska A; Warchol I; Gora M; Kaminska J; Plochocka D; Wysocka-Kapcinska M; Tulacz D; Siedlecka J; Swiezewska E; Sojka M; Danikiewicz W; Odolczyk N; Szkopinska A; Sygitowicz G; Burzynska B
BMC Biotechnol; 2013 Aug; 13():68. PubMed ID: 24128347
[TBL] [Abstract][Full Text] [Related]
12. Potential antitumor effects of statins (Review).
Jakobisiak M; Golab J
Int J Oncol; 2003 Oct; 23(4):1055-69. PubMed ID: 12963986
[TBL] [Abstract][Full Text] [Related]
13. How do statins control neuroinflammation?
Adamson P; Greenwood J
Inflamm Res; 2003 Oct; 52(10):399-403. PubMed ID: 14520514
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.
Wang CY; Liu PY; Liao JK
Trends Mol Med; 2008 Jan; 14(1):37-44. PubMed ID: 18068482
[TBL] [Abstract][Full Text] [Related]
15. Statins and protein prenylation in cancer cell biology and therapy.
Garcia-Ruiz C; Morales A; Fernandez-Checa JC
Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
[TBL] [Abstract][Full Text] [Related]
16. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases.
Willey JZ; Elkind MS
Arch Neurol; 2010 Sep; 67(9):1062-7. PubMed ID: 20837848
[TBL] [Abstract][Full Text] [Related]
17. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
Katz MS
Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
20. Targeting tumor cell metabolism with statins.
Clendening JW; Penn LZ
Oncogene; 2012 Nov; 31(48):4967-78. PubMed ID: 22310279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
